Skip to main content

Table 1 Clinical and demographic features of patients with non-131I-avid and 131I-avid lungs metastases

From: miRNA-106a directly targeting RARB associates with the expression of Na+/I symporter in thyroid cancer by regulating MAPK signaling pathway

Clinical Characteristics Groups P value
non-131I-avid (N = 47) 131I-avid (N = 72)
Age/years    0.55
 Median (range) 43 (28–60) 42 (27–55)  
Gender    0.90
 Male (%) 21 (44.7) 33 (45.8)  
 Female (%) 26 (55.3) 39 (54.2)  
Tg level (ng/ml)    0.77
 Median (range) 1213.5 (304.7–3121.9) 1324.3 (324.9–3249.5)  
TgAb level (IU/ml)    0.72
 Median (range) 45.6 (10–125.6) 43.8 (10–150.3)  
Histological diagnosis PTC PTC
Primary tumor   
T stage   
 T1 17 27
 T2 19 30
 T3 9 12
 T4 2 3
N stage   
 N0 0 0
 N1 46 70
 Nx 1 2
Chest CT scan Diffuse small nodules Diffuse small nodules
131I up take in lungs Close to upper limbs Diffuse lung uptake
Extent of disease No other metastasis No other metastasis
Other cancer history No No
Other treatment No No